LIC Launches BIMA Lakshmi: Exclusive Women’s Insurance Plan

LIC has introduced BIMA Lakshmi, an insurance plan exclusively for women aged 18–50. The policy term is 25 years, with flexible payment terms ranging from 7 to 15 years. It starts with a minimum sum assured of ₹2,00,000 and offers multiple money-back options, giving policyholders financial flexibility throughout the policy tenure.

Money-Back & Maturity Benefits

BIMA Lakshmi provides three money-back options:

• Option A: 50% after the premium payment term ends
• Option B: 7.5% at the end of every 2 years
• Option C: 15% at the end of every 4 years

At maturity, the policyholder receives the sum on maturity plus Guaranteed Additions (GA), calculated at 7% of the tabular annual premium, with additional incentives up to 0.5% for existing LIC customers. The plan also allows deferment of money-back benefits to suit individual needs.

Comprehensive Cover and Riders

The policy provides sum assured on death plus GA, with the death benefit not less than 105% of premiums paid. Optional riders include:

• Accidental Death & Disability Benefit Rider
• Accident Benefit Rider
• LIC Female Critical Illness Rider covering early-stage cancer, common female surgeries, pregnancy complications, and congenital anomalies. Module-wise coverage ranges from 1–4 lakh with payouts up to 200%.

Flexibility & Additional Features

All premium modes are allowed, with e-NACH preferred for monthly payments. The plan offers loans, auto cover, assignment, early exit, and settlement options, along with flexible money-back and maturity choices.

Also Read: LIC Jan Suraksha Scheme: All You Need to Know!

Conclusion

LIC’s BIMA Lakshmi combines wealth accumulation, health security, and critical illness protection in a single plan. Tailored for women, it ensures both financial and health safety, making it an ideal choice for long-term planning.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.